Preliminary study of two antiviral agents for hepatitis C genotype 1

Ver

Role of the routine use of chest computed tomography and bone scan in staging workup of hepatocellular carcinoma

Ver

Regular coffee but not espresso drinking is protectiveagainst fibrosis in a cohort mainly composed of morbidly obese European women with NASH undergoing bariatric surgery

Ver

Short course adjuvant terlipressin in acute variceal bleeding:a randomized double blind dummy controlled trial

Ver

Risk factors of resistance to ceftriaxona and its impact in mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis

Ver

Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding: a cohort study

Ver

C-reactive protein predicts short term mortality in patients with cirrhosis

Ver

Non-alcoholic fatty liver disease across the spectrum of hypothyroidism

Ver

Noradrenalina vs terlipressin in the treatment of hepatorrenal syndrome: a randomized study

Ver

Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patients survival

Ver

C-reactive protein predicts short term mortality in patients with cirrhosis

Ver

Serum ferritin is an independent predictor of histologic severity and advance fibrosis in patients with non alcoholic fatty liver disease

Ver

Prognostic importance of the cause of renal failure in patients with cirrhosis

Ver

Impact of peginterferon and ribavirin therapy in hepatocellular carcinoma: incidence and survival in hepatitis C patients with advance fibrosis

Ver

Severe hyponatremia is better predictor of mortality than MELDna in patients with cirrhosis and refractory ascites

Ver

Survival of patients with hepaticellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads

Ver

Non-invasive diagnosis hepatocellular carcinoma <2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI

Ver

Serum DKK1as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large scale, multicenter study

Ver

Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose vs no lactulose

Ver

Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non alcoholic fatty liver disease (NAFLD)

Ver

von Willebrand factor as a new non-invasive predictor of portal hypertension, decompesation, and mortality in patients with liver cirrhosis

Ver

 

2016 - 2015 - 2014 - 2013 -2012 -2011 -2010 - 2009

 

 
 

 

 

Dirección: Urquiza 3100, Rosario (2000), Santa Fe, Argentina
e-mail: contactohepagastro@gmail.com
TEL: 0341-4393511

Diseño web IDEAS MED | Tabone Juan Pablo | www.ideasmed.com.ar |

Hepagastro | Dr. Federico Tanno | Todos los derechos reservados 2015.-